JP2010507363A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010507363A5 JP2010507363A5 JP2009533438A JP2009533438A JP2010507363A5 JP 2010507363 A5 JP2010507363 A5 JP 2010507363A5 JP 2009533438 A JP2009533438 A JP 2009533438A JP 2009533438 A JP2009533438 A JP 2009533438A JP 2010507363 A5 JP2010507363 A5 JP 2010507363A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- virus
- vero cells
- cell culture
- supernatant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000700605 Viruses Species 0.000 claims description 41
- IPCSVZSSVZVIGE-UHFFFAOYSA-N Palmitic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 19
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 18
- OYHQOLUKZRVURQ-IXWMQOLASA-N Linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 18
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims description 18
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N Oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 18
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 18
- DTOSIQBPPRVQHS-PDBXOOCHSA-N α-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 18
- SECPZKHBENQXJG-FPLPWBNLSA-N Palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 claims description 16
- 210000003501 Vero Cells Anatomy 0.000 claims description 13
- 150000002632 lipids Chemical class 0.000 claims description 11
- 239000006143 cell culture media Substances 0.000 claims description 10
- 239000012141 concentrate Substances 0.000 claims description 10
- 229940107161 Cholesterol Drugs 0.000 claims description 9
- 229960004488 Linolenic Acid Drugs 0.000 claims description 9
- 235000021360 Myristic acid Nutrition 0.000 claims description 9
- 239000005642 Oleic acid Substances 0.000 claims description 9
- 235000021314 Palmitic acid Nutrition 0.000 claims description 9
- 235000021355 Stearic acid Nutrition 0.000 claims description 9
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 9
- 235000012000 cholesterol Nutrition 0.000 claims description 9
- 235000019441 ethanol Nutrition 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 235000020778 linoleic acid Nutrition 0.000 claims description 9
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 9
- 229920000053 polysorbate 80 Polymers 0.000 claims description 9
- 239000008117 stearic acid Substances 0.000 claims description 9
- 235000021319 Palmitoleic acid Nutrition 0.000 claims description 8
- 229920001993 poloxamer 188 Polymers 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 238000004113 cell culture Methods 0.000 claims description 6
- 201000009910 diseases by infectious agent Diseases 0.000 claims description 4
- 239000011627 DL-alpha-tocopherol Substances 0.000 claims description 2
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 238000010899 nucleation Methods 0.000 claims description 2
- 230000001902 propagating Effects 0.000 claims description 2
- 229960000984 tocofersolan Drugs 0.000 claims description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 2
- 239000006228 supernatant Substances 0.000 description 19
- 239000002609 media Substances 0.000 description 16
- 210000004027 cells Anatomy 0.000 description 10
- 229940114079 Arachidonic Acid Drugs 0.000 description 8
- YZXBAPSDXZZRGB-DOFZRALJSA-N Arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 8
- 235000021342 arachidonic acid Nutrition 0.000 description 8
- 235000021313 oleic acid Nutrition 0.000 description 8
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-α-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 7
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 7
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 7
- 210000002966 Serum Anatomy 0.000 description 7
- 229960001452 alpha-Tocopherol Acetate Drugs 0.000 description 7
- 241000712005 Bovine respirovirus 3 Species 0.000 description 4
- 229920001850 Nucleic acid sequence Polymers 0.000 description 4
- 241000724205 Rice stripe tenuivirus Species 0.000 description 4
- 241001493065 dsRNA viruses Species 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 2
- 101700002316 HN Proteins 0.000 description 2
- 241000351643 Metapneumovirus Species 0.000 description 2
- 241000725643 Respiratory syncytial virus Species 0.000 description 2
- 108091006028 chimera Proteins 0.000 description 2
- 230000000241 respiratory Effects 0.000 description 2
- 229960005486 vaccines Drugs 0.000 description 2
- 241000699800 Cricetinae Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108060003023 F Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108010061543 Neutralizing Antibodies Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- -1 ammonium ions Chemical class 0.000 description 1
- 108090001123 antibodies Proteins 0.000 description 1
- 102000004965 antibodies Human genes 0.000 description 1
- 230000002238 attenuated Effects 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001963 growth media Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000644 propagated Effects 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86255006P | 2006-10-23 | 2006-10-23 | |
| PCT/US2007/066037 WO2007118134A2 (en) | 2006-04-06 | 2007-04-05 | A serum-free virus propagation platform for a virus vaccine candidate |
| US94416207P | 2007-06-15 | 2007-06-15 | |
| US97392107P | 2007-09-20 | 2007-09-20 | |
| PCT/US2007/080610 WO2008051698A2 (en) | 2006-10-23 | 2007-10-05 | A serum-free virus propagation platform for a virus vaccine candidate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010507363A JP2010507363A (ja) | 2010-03-11 |
| JP2010507363A5 true JP2010507363A5 (zh) | 2010-11-25 |
Family
ID=40691374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009533438A Pending JP2010507363A (ja) | 2006-10-23 | 2007-10-05 | ウイルスワクチン候補のための無血清ウイルス増殖プラットフォーム |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP2076603A4 (zh) |
| JP (1) | JP2010507363A (zh) |
| KR (1) | KR20090084859A (zh) |
| BR (1) | BRPI0717469A2 (zh) |
| WO (1) | WO2008051698A2 (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101875917B (zh) * | 2009-04-28 | 2012-07-04 | 北京清大天一科技有限公司 | 生物反应器微载体培养动物细胞生产猪瘟疫苗的方法 |
| EP3656855A1 (en) * | 2011-04-18 | 2020-05-27 | The Trustees of Princeton University | Method to produce virus in cultured cells |
| JP6917984B2 (ja) * | 2016-05-09 | 2021-08-11 | 協和発酵バイオ株式会社 | 培地、アルブミン非含有培地用添加剤および多能性幹細胞の培養方法 |
| KR20200044973A (ko) * | 2017-09-15 | 2020-04-29 | 라이프 테크놀로지스 코포레이션 | 세포를 배양 및 팽창시키기 위한 조성물 및 방법 |
| WO2024075819A1 (ja) * | 2022-10-07 | 2024-04-11 | Ａｇｃ株式会社 | 細胞を用いたウイルスベクターの生産方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007118134A2 (en) * | 2006-04-06 | 2007-10-18 | Medimmune, Inc. | A serum-free virus propagation platform for a virus vaccine candidate |
-
2007
- 2007-10-05 JP JP2009533438A patent/JP2010507363A/ja active Pending
- 2007-10-05 KR KR1020097009590A patent/KR20090084859A/ko not_active Application Discontinuation
- 2007-10-05 EP EP07853807A patent/EP2076603A4/en not_active Withdrawn
- 2007-10-05 WO PCT/US2007/080610 patent/WO2008051698A2/en active Application Filing
- 2007-10-05 BR BRPI0717469-1A2A patent/BRPI0717469A2/pt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102216450B (zh) | 培养细胞、增殖和纯化病毒的方法 | |
| US11629339B2 (en) | Aseptic purification process for viruses | |
| CN102215865A (zh) | 病毒纯化方法 | |
| JP2010507363A5 (zh) | ||
| CN112458064A (zh) | 盖他病毒全长感染性克隆、复制子系统及其制备和应用 | |
| CN107267532B (zh) | PEDV JS2008株全长感染性cDNA的构建方法及应用 | |
| EP4028511A1 (en) | Inactivation process for viruses | |
| US10080793B2 (en) | Methods for the prevention of aggregation of viral components | |
| Göbel et al. | Process intensification strategies toward cell culture‐based high‐yield production of a fusogenic oncolytic virus | |
| US20220098555A1 (en) | Method for virus production | |
| CN112094814A (zh) | 一种通过灌流培养工艺制备腺病毒载体疫苗的方法 | |
| EP2456855B1 (en) | Drain down and re-feed of microcarrier bioreactor | |
| CN111440770A (zh) | 人源细胞悬浮培养的培养基组合及溶瘤痘苗病毒的制备方法 | |
| CN112126629B (zh) | 一种耐热新城疫病毒突变株及其制备方法与应用 | |
| EP2155863B1 (en) | Two-step temperature profile for the propagation of viruses | |
| CN113005100A (zh) | 一种改变囊膜病毒热稳定性的遗传改造方法及重组病毒与其应用 | |
| US20100143889A1 (en) | Rhabdoviridae virus preparations | |
| CN115537379B (zh) | 一种用于培养mdck细胞及扩增病毒的组合培养基及其应用 | |
| CN117070476B (zh) | 一株牛疱疹病毒4型毒株及其在灭活疫苗制备中的应用 | |
| CN113736826A (zh) | 一种广谱型的新城疫病毒全基因组扩增引物和扩增方法 | |
| Genzel et al. | Influenza vaccines–challenges in mammalian cell culture technology | |
| CN105602909A (zh) | 一种猪伪狂犬病毒的培养方法 | |
| CN115537378A (zh) | 一种对hek293细胞进行悬浮培养的方法及其培养基 | |
| Losa | Production of a VSV-Vectored Ebola Vaccine Candidate with the Vero Cell Line | |
| CN118006566A (zh) | 病毒保护剂及病毒的培养方法 |